777 participants
Median age 37 years, 69.5% women
40 participants (5.1%) had elevated high-sensitivity cardiac troponin T concentration on day 3
(Taken as above the 99th percentile for age and sex)
mRNA-1273 vaccine-associated myocardial injury was adjudicated in 22 participants (2.8%).
One in 35 recipients (2.8%) had vaccine-associated myocardial injury
Conclusion
mRNA-1273 vaccine-associated myocardial injury was more common than previously thought,
being mild and transient,
and more frequent in women versus men.
777 participants
Median age 37 years, 69.5% women
40 participants (5.1%) had elevated high-sensitivity cardiac troponin T concentration on day 3
(Taken as above the 99th percentile for age and sex)
mRNA-1273 vaccine-associated myocardial injury was adjudicated in 22 participants (2.8%).
*One in 35 recipients (2.8%) had vaccine-associated myocardial injury*
**Conclusion**
mRNA-1273 vaccine-associated myocardial injury was more common than previously thought,
being mild and transient,
and more frequent in women versus men.
(post is archived)